CANADA LIFE ASSURANCE Co cut its holdings in Itron, Inc. (NASDAQ:ITRI - Free Report) by 12.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 57,685 shares of the scientific and technical instruments company's stock after selling 8,511 shares during the period. CANADA LIFE ASSURANCE Co owned approximately 0.13% of Itron worth $6,262,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Proficio Capital Partners LLC bought a new stake in shares of Itron in the fourth quarter worth about $30,000. Hager Investment Management Services LLC bought a new stake in shares of Itron in the 4th quarter worth approximately $67,000. Contravisory Investment Management Inc. grew its position in shares of Itron by 154.9% in the 4th quarter. Contravisory Investment Management Inc. now owns 864 shares of the scientific and technical instruments company's stock worth $94,000 after buying an additional 525 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Itron by 347.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 886 shares of the scientific and technical instruments company's stock valued at $97,000 after acquiring an additional 688 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Itron by 15.6% in the fourth quarter. GAMMA Investing LLC now owns 1,177 shares of the scientific and technical instruments company's stock worth $128,000 after acquiring an additional 159 shares during the period. 96.19% of the stock is owned by institutional investors.
Itron Stock Down 1.2 %
Itron stock traded down $1.31 during mid-day trading on Monday, hitting $109.10. The company had a trading volume of 489,845 shares, compared to its average volume of 573,668. Itron, Inc. has a 12 month low of $90.03 and a 12 month high of $124.90. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91. The stock's 50 day moving average price is $103.32 and its two-hundred day moving average price is $107.44. The company has a market capitalization of $4.97 billion, a PE ratio of 22.36, a price-to-earnings-growth ratio of 0.81 and a beta of 1.39.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on ITRI. Canaccord Genuity Group boosted their price objective on shares of Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Oppenheimer raised their price objective on shares of Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a report on Wednesday, February 26th. StockNews.com cut Itron from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 1st. Guggenheim reissued a "buy" rating and issued a $133.00 target price on shares of Itron in a research report on Thursday, April 17th. Finally, Piper Sandler lifted their price target on Itron from $119.00 to $124.00 and gave the company a "neutral" rating in a research report on Thursday, February 27th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, Itron currently has a consensus rating of "Moderate Buy" and an average target price of $127.64.
View Our Latest Stock Analysis on Itron
Insider Buying and Selling
In related news, SVP Christopher E. Ware sold 648 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $60,199.20. Following the transaction, the senior vice president now directly owns 20,326 shares of the company's stock, valued at approximately $1,888,285.40. This represents a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Mary C. Hemmingsen sold 750 shares of Itron stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $107.27, for a total value of $80,452.50. Following the completion of the sale, the director now directly owns 5,630 shares of the company's stock, valued at approximately $603,930.10. The trade was a 11.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,037 shares of company stock worth $385,815 in the last quarter. Corporate insiders own 1.45% of the company's stock.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Further Reading
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
